As we recently announced, Absci is collaborating with Twist to design a novel antibody ... studies as planned and our company and our program's ability to potentially demonstrate a truly ...
Nov. 12, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Corvus or the Company) (Nasdaq: CRVS), a clinical-stage ... and with a more convenient and tolerable profile than biologics.” Business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback